Nestle, CDI partner to develop nutritional drinks, smoothies
Nestlé Institute of Health Sciences (NIHS), the research arm of Nestlé, has signed a long-term supply agreement with Cellular Dynamics International (CDI) for iCell and MyCell products to develop nutritionally enhanced drinks, smoothies and other products.
CDI's iCell product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development.
The company's MyCell Products are cell products manufactured from donor samples using iPSC technology to make stem cells or differentiated cells from any individual, including those with diseases of interest.
NIHS director Emmanuel Baetge told The Wall Street Journal that under the deal, Nestlé will study how nutrients found in food and drinks affect these human cells.
Using the information, Nestlé plans to develop nutritionally enhanced drinks, smoothies and other products in response to growing demand for medical foods that will help in reducing the risks of obesity, diabetes and Alzheimer's.
The financial terms of the agreement were not disclosed.
Founded in 1866, Nestlé, together with its subsidiaries, provides nutrition, health and wellness products across the globe.
Image: Nestle to develop nutritional drinks from stem cells. Photo courtesy of KEKO64/FreeDigitalPhotos.net.